(UroToday.com) The treatment for metastatic hormone-sensitive prostate cancer plenary session at the European Association of Urology 2021 Meeting included a presentation by Dr. Tobias Maurer discussing the role of imaging-guided surgical treatment for recurrent metastatic hormone sensitive prostate cancer (mHSPC). Dr. Maurer started his presentation by emphasizing that the most recent EAU guidelines do not favor salvage lymph node dissection, given the lack of high-level evidence for oncological efficacy.